Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Kraig Biocraft Laboratories (KBLB) Operating Margin (2016 - 2022)

Kraig Biocraft Laboratories (KBLB) has disclosed Operating Margin for 6 consecutive years, with 693.69% as the latest value for Q4 2022.

  • Quarterly Operating Margin rose 129276619.0% to 693.69% in Q4 2022 from the year-ago period, while the trailing twelve-month figure was 348.26% through Dec 2022, down 51780.0% year-over-year, with the annual reading at 205.5% for FY2025, 37504.0% down from the prior year.
  • Operating Margin hit 693.69% in Q4 2022 for Kraig Biocraft Laboratories, down from 702.74% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 702.74% in Q3 2022 to a low of 1292072.5% in Q4 2021.
  • Historically, Operating Margin has averaged 128959.97% across 3 years, with a median of 258.46% in 2022.
  • Biggest YoY gain for Operating Margin was 129276619bps in 2022; the steepest drop was -17344bps in 2022.
  • Year by year, Operating Margin stood at 105.11% in 2018, then tumbled by -1229206bps to 1292072.5% in 2021, then surged by 100bps to 693.69% in 2022.
  • Business Quant data shows Operating Margin for KBLB at 693.69% in Q4 2022, 702.74% in Q3 2022, and 179.82% in Q2 2022.